Leishmania donovani

Experimental Therapeutics
Nanotized Curcumin and Miltefosine, a Potential Combination for Treatment of Experimental Visceral Leishmaniasis
Brajendra Tiwari, Richa Pahuja, Pradeep Kumar, Srikanta Kumar Rath, Kailash Chand Gupta, Neena Goyal
Mechanisms of Action: Physiological Effects
Snapshot Profiling of the Antileishmanial Potency of Lead Compounds and Drug Candidates against Intracellular Leishmania donovani Amastigotes, with a Focus on Human-Derived Host Cells
Markela Koniordou, Stephen Patterson, Susan Wyllie, Karin Seifert
Experimental Therapeutics
Antileishmanial and Antitrypanosomal Activities of the 8-Aminoquinoline Tafenoquine
Vanessa Yardley, Francisco Gamarro, Simon L. Croft
Susceptibility
In Vitro Susceptibilities of Leishmania donovani Promastigote and Amastigote Stages to Antileishmanial Reference Drugs: Practical Relevance of Stage-Specific Differences
Marieke Vermeersch, Raquel Inocêncio da Luz, Kim Toté, Jean-Pierre Timmermans, Paul Cos, Louis Maes
Mechanisms of Resistance
Topoisomerase I Gene Mutations at F270 in the Large Subunit and N184 in the Small Subunit Contribute to the Resistance Mechanism of the Unicellular Parasite Leishmania donovani towards 3,3′-Diindolylmethane
Amit Roy, Somdeb BoseDasgupta, Agneyo Ganguly, Parasuraman Jaisankar, Hemanta K. Majumder
Susceptibility
In Vitro Susceptibility of Field Isolates of Leishmania donovani to Miltefosine and Amphotericin B: Correlation with Sodium Antimony Gluconate Susceptibility and Implications for Treatment in Areas of Endemicity
Dhiraj Kumar, Arpita Kulshrestha, Ruchi Singh, Poonam Salotra
Susceptibility
Antiparasitic Activities and Toxicities of Individual Enantiomers of the 8-Aminoquinoline 8-[(4-Amino-1-Methylbutyl)Amino]-6-Methoxy-4-Methyl-5-[3,4-Dichlorophenoxy]Quinoline Succinate
N. P. Dhammika Nanayakkara, Arba L. Ager, Marilyn S. Bartlett, Vanessa Yardley, Simon L. Croft, Ikhlas A. Khan, James D. McChesney, Larry A. Walker
Mechanisms of Resistance
Inhibition of ABC Transporters Abolishes Antimony Resistance in Leishmania Infection
Jayati Mookerjee Basu, Ananda Mookerjee, Rajdeep Banerjee, Manik Saha, Subhankar Singh, Ksudiram Naskar, Gayetri Tripathy, Prabhat K. Sinha, Krishna Pandey, Shyam Sundar, Sanjeev Bimal, Pradip K. Das, Soumitra K. Choudhuri, Syamal Roy
Mechanisms of Action: Physiological Effects
Modulation of Gene Expression in Human Macrophages Treated with the Anti-Leishmania Pentavalent Antimonial Drug Sodium Stibogluconate
Karima El Fadili, Michaël Imbeault, Nadine Messier, Gaétan Roy, Benjamin Gourbal, Marc Bergeron, Michel J. Tremblay, Danielle Légaré, Marc Ouellette
Experimental Therapeutics
Oral Therapy with Amlodipine and Lacidipine, 1,4-Dihydropyridine Derivatives Showing Activity against Experimental Visceral Leishmaniasis
Partha Palit, Nahid Ali

Pages